Papers - KATSUNO, Masahisa
-
Naratriptan mitigates CGRP1-associated motor neuron degeneration caused by expanded polyglutamine. Reviewed
Minamiyama M, Katsuno M, Adachi H, Doi H, Kondo N, Iida M, Ishigaki S, Fujioka Y, Matsumoto S, Miyazaki Y, Tanaka F, Kurihara H, Sobue G.
Nat Med. Vol. 18 page： 1531-1538 2012
-
Longitudinal changes of outcome measures in spinal and bulbar muscular atrophy. Reviewed
Hashizume A, Katsuno M, Banno H, Suzuki K, Suga N, Mano T, Atsuta N, Oe H, Watanabe H, Tanaka F, Sobue G.
Brain Vol. 135 page： 2838-2848 2012
-
TSUNAMI: an antisense method to phenocopy splicing-associated diseases in animals.
Sahashi K, Hua Y, Ling KK, Hung G, Rigo F, Horev G, Katsuno M, Sobue G, Ko CP, Bennett CF, Krainer AR.
Genes Dev. Vol. 26 page： 1874-84 2012
-
Cross-sectional and longitudinal analysis of an oxidative stress biomarker for spinal and bulbar muscular atrophy (SBMA). Reviewed
Mano T, Katsuno M, Banno H, Suzuki K, Suga N, Hashizume A, Tanaka F, Sobue G.
Muscle Nerve Vol. 46 page： 692-697 2012
-
Viral delivery of miR-196a ameliorates the SBMA phenotype via the silencing of CELF2. Reviewed
Miyazaki Y, Adachi H, Katsuno M, MInamiyama M, Jiang YM, Huang Z, Doi H, Matsumoto S, Kondo N, Iida M, Tohnai G, Tanaka F, Muramatsu S, Sobue G.
Nat Med. Vol. 18 page： 1136-1141 2012
-
Position-dependent FUS-RNA interactions regulate alternative splicing events and transcriptions. Reviewed
Ishigaki S, Masuda A, Fujioka Y, Iguchi Y, Katsuno M, Shibata A, Urano F, Sobue G, Ohno K.
Sci Rep. Vol. 2 page： 529 2012
-
Molecular pathophysiology and disease-Modifying therapies for spinal and bulbar muscular atrophy. Invited Reviewed
Katsuno M, Banno H, Suzuki K, Adachi H, Tanaka F, Sobue G.
Arch Neurol. Vol. 69 page： 436-440 2012
-
Differential change of clinical outcome measures in spinal and bulbar muscular atrophy: comparison of natural history with placebo-treated group. Reviewed
Hashizume A, Katsuno M, Banno H, Suzuki K, Suga N, Tanaka F, Sobue G.
J Neurol. Vol. 259 page： 712-719 2012
-
Perspectives on molecular targeted therapies and clinical trials for neurodegenerative diseases. Invited Reviewed
Katsuno M, Tanaka F, Sobue G.
J Neurol Neurosurg Psychiatry Vol. 83 page： 329-335 2012
-
Transforming growth factor-beta signaling in motor neuron diseases. Invited Reviewed
Katsuno M, Adachi H, Banno H, Suzuki K, Tanaka F, Sobue G.
Current Mol Med. Vol. 11 page： 48-56 2011
-
Macroautophagy Is Regulated by the UPR-Mediator CHOP and Accentuates the Phenotype of SBMA Mice. Reviewed
Yu Z, Wang AM, Adachi H, Katsuno M, Sobue G, Yue Z, Robins DM, Lieberman AP.
PLoS Genet. Vol. 7 page： e1002321 2011
-
Dutasteride for spinal and bulbar muscular atrophy: another advance towards disease-modifying therapy. Invited Reviewed
Banno H, Katsuno M, Suzuki K, Sobue G.
Lancet Neurol. Vol. 10 page： 113-115 2011
-
The profile of motor unit number estimation (MUNE) in spinal and bulbar muscular atrophy. Reviewed
Suzuki K, Katsuno M, Banno H, Takeuchi Y, Kawashima M, Suga N, Hashizume A, Hama T, Uchida K, Yamashita F, Nakamura T, Hirayama M, Tanaka F, Sobue G.
J Neurol Neurosurg Psychiatry Vol. 81 page： 567-571 2010
-
Clinical features and molecular mechanisms of spinal and bulbar muscular atrophy (SBMA). Invited Reviewed
Katsuno M, Banno H, Suzuki K, Adachi H, Tanaka F, Sobue G.
Adv Exp Med Biol. Vol. 685 page： 64-74 2010
-
Efficacy and safety of leuprorelin in patients with spinal and bulbar muscular atrophy (JASMITT study): a multicentre, randomised, double-blind, placebo-controlled trial. Reviewed
Katsuno M, Banno H, Suzuki K, Takeuchi Y, Kawashima M, Yabe I, Sasaki H, Aoki M, Morita M, Nakano I, Kanai K, Ito S, Ishikawa K, Mizusawa H, Yamamoto T, Tsuji S, Hasegawa K, Shimohata T, Nishizawa M, Miyajima H, Kanda F, Watanabe Y, Nakashima K, Tsujino A, Yamashita T, Uchino M, Fujimoto Y, Tanaka F, Sobue G; for the Japan SBMA Interventional Trial for TAP-144-SR (JASMITT) study group.
Lancet Neurol. Vol. 9 page： 875-884 2010
-
Disrupted TGF-beta signaling in spinal and bulbar muscular atrophy. Reviewed
Katsuno M, Adachi H, Minamiyama M, Waza M, Doi H, Kondo N, Mizoguchi H, Nitta A, Yamada K, Banno H, Suzuki K, Tanaka F, Sobue G.
J Neurosci. Vol. 30 page： 5702-5712 2010
-
17-DMAG ameliorates polyglutamine-mediated motor neuron degeneration through well-preserved proteasome function in a SBMA model mouse. Reviewed
Tokui K, Adachi H, Waza M, Katsuno M, Minamiyama M, Doi H, Tanaka K, Hamazaki J, Murata S, Tanaka F, Sobue G.
Hum Mol Genet Vol. 18 page： 898-910 2009
-
Heat shock proteins in neurodegenerative diseases: Pathogenic roles and therapeutic implications. Reviewed
Adachi H, Katsuno M, Waza M, Minamiyama M, Tanaka F, Sobue G.
Int J Hyperthermia Vol. 25 page： 647-654 2009
-
Correlation between pyramidal tract degeneration and widespread white matter involvement in amyotrophic lateral sclerosis: a study with tractography and diffusion-tensor imaging. Reviewed
Senda J, Ito M, Watanabe H, Atsuta N, Kawai Y, Katsuno M, Tanaka F, Naganawa S, Fukatsu H, Sobue G.
Amyotroph Lateral Scler. Vol. 10 page： 288-294 2009
-
Single nucleotide polymorphism of TAG-1 influences IVIg responsiveness of Japanese patients with CIDP. Reviewed
Iijima M, Tomita M, Morozumi S, Kawagashira Y, Nakamura T, Koike H, Katsuno M, Hattori N, Tanaka F, Yamamoto M, Sobue G.
Neurology Vol. 73 page： 1348-1352 2009